"Generic" Biologics Hearing Set By Sen. Hatch; FDA Expected To Testify
This article was originally published in The Pink Sheet Daily
Executive Summary
Witnesses at June 23 hearing are expected to include Acting Commissioner Crawford and Chief Counsel Troy, as well as representatives from the generic and biotech industries.